These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 12841387

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0.
    Suzuki R, Ohtake S, Takeuchi J, Nagai M, Kodera Y, Hamaguchi M, Miyawaki S, Karasuno T, Shimodaira S, Ohno R, Nakamura S, Naoe T.
    Int J Hematol; 2010 Mar; 91(2):303-9. PubMed ID: 20111912
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transient myeloproliferative disorder with a CD7+ and CD56+ myeloid/natural killer cell precursor phenotype in a newborn.
    Svaldi M, Moroder W, Messner H, Battisti L, Venturi R, Coser P, Mitterer M.
    J Pediatr Hematol Oncol; 2002 Mar; 24(5):394-6. PubMed ID: 12142790
    [Abstract] [Full Text] [Related]

  • 5. Minimally differentiated acute myeloid leukemia in Taiwan: predominantly occurs in children less than 3 years and adults between 51 and 70 years.
    Huang SY, Tang JL, Jou ST, Tsay W, Hu CH, Lin DT, Lin KS, Lin KS, Wang CH, Chen YC, Shen MC, Tien HF.
    Leukemia; 1999 Oct; 13(10):1506-12. PubMed ID: 10516750
    [Abstract] [Full Text] [Related]

  • 6. Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia.
    El-Sissy AH, El-Mashari MA, Bassuni WY, El-Swaayed AF.
    J Egypt Natl Canc Inst; 2006 Sep; 18(3):244-9. PubMed ID: 17671534
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical Features and Prognosis of 227 cases of Acute Myeloid Leukemia with Cross-lineage Antigen Expression].
    Fang F, Zhu P, Zhang Y, Lu XZ, Dong YJ, Sun YH, Wang LH, Bu DF, Cen XN, Wang MJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):990-7. PubMed ID: 27531762
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G.
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA.
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [Abstract] [Full Text] [Related]

  • 17. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0).
    Stasi R, Del Poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G.
    Blood; 1994 Mar 15; 83(6):1619-25. PubMed ID: 8123853
    [Abstract] [Full Text] [Related]

  • 18. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Mar 15; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 19. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Handa H, Motohashi S, Isozumi K, Komatsumoto S, Nara M.
    Acta Haematol; 2002 Mar 15; 108(1):47-52. PubMed ID: 12145468
    [Abstract] [Full Text] [Related]

  • 20. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG, Chen XM, Zhu HL, Zhong L, Zeng TT, Jia YQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec 15; 18(6):1405-9. PubMed ID: 21176339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.